Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study
Open Access
- 4 December 2012
- journal article
- Published by Springer Nature in BMC Clinical Pathology
- Vol. 12 (1) , 23
Abstract
CA19-9 is a tumor marker mainly used for biliary tract, pancreas and colorectum. Since the marker applies usually for adults, the normal range of serum CA19-9 among children has been rarely reported. This is the first study reporting the distribution of serum CA19-9 levels among cancer-free children as well as their parents, taking into account the Lewis and secretor gene polymorphism and physical growth.Keywords
This publication has 20 references indexed in Scilit:
- The Clinical Significance in Healthy Men of the Association Between Obesity Related Plasma Hemodilution and Tumor Marker ConcentrationJournal of Urology, 2009
- Smoking and serum CA19‐9 levels according to Lewis and secretor genotypesInternational Journal of Cancer, 2008
- Prognostic Relevance of Carbohydrate Antigen 19-9 Levels in Patients with Advanced Biliary Tract CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Association of Lewis and Secretor gene polymorphisms and Helicobacter pylori seropositivity among Japanese-BraziliansJournal of Gastroenterology, 2004
- Polymerase Chain Reaction with Confronting Two‐pair Primers for Polymorphism GenotypingJapanese Journal of Cancer Research, 2000
- A CASE OF MALIGNANT LYMPHOMA IN A PATIENT WITH HIGH LEVELS OF CA125 AND CA19-9Pediatric Hematology and Oncology, 2000
- Giant Hydronephrosis due to a Ureteral Stone, and Elevated Serum Levels of CA 19-9.Internal Medicine, 1999
- DNA Sequencing and Screening for Point Mutations in the Human Lewis (FUT3) Gene Enables Molecular Genotyping of the Human Lewis Blood Group SystemVox Sanguinis, 1996
- CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitisEuropean Journal of Cancer and Clinical Oncology, 1985
- Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinomaJournal of Clinical Immunology, 1982